Long-term second-line chemotherapy consisting of oral S-1 and gemcitabine for NSCLC: A phase II study—TORG 0705.

2010 ◽  
Vol 28 (15_suppl) ◽  
pp. e18007-e18007
Author(s):  
Y. Takiguchi ◽  
T. Seto ◽  
Y. Ichinose ◽  
N. Nogami ◽  
H. Okamoto ◽  
...  
Keyword(s):  
Phase Ii ◽  
Phase Ii Study ◽  
Second Line ◽  
Second Line Chemotherapy ◽  
Line Chemotherapy

FOLFIRI as second-line chemotherapy for advanced pancreatic cancer: a GISCAD multicenter phase II study

2012 ◽  
Vol 69 (6) ◽  
pp. 1641-1645 ◽  
Author(s):  
Alberto Zaniboni ◽  
Enrico Aitini ◽  
Sandro Barni ◽  
Daris Ferrari ◽  
Stefano Cascinu ◽  
...  
Keyword(s):  
Pancreatic Cancer ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Advanced Pancreatic Cancer ◽  
Second Line ◽  
Second Line Chemotherapy ◽  
Multicenter Phase ◽  
Line Chemotherapy

scholarly journals Biweekly Irinotecan and Cisplatin as Second-line Chemotherapy in Pretreated Patients with Advanced Gastric Cancer: A Multicenter Phase II Study

2005 ◽  
Vol 20 (6) ◽  
pp. 966 ◽  
Author(s):  
Jin Ho Baek ◽  
Jong Gwang Kim ◽  
Sang Kyun Sohn ◽  
Dong Hwan Kim ◽  
Kyu Bo Lee ◽  
...  
Keyword(s):  
Gastric Cancer ◽  
Advanced Gastric Cancer ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Second Line ◽  
Second Line Chemotherapy ◽  
Multicenter Phase ◽  
Pretreated Patients ◽  
Line Chemotherapy

Phase II Study of Gemcitabine and Vinorelbine as Second-Line Chemotherapy in Non-Small Cell Lung Cancer

2003 ◽  
Vol 35 (4) ◽  
pp. 294-298
Author(s):  
Yoon Jae Kim ◽  
Joo Hyuk Sohn ◽  
Chul Kim ◽  
Yong Tai Kim ◽  
Hai Jin Kim ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Phase Ii ◽  
Cell Lung Cancer ◽  
Phase Ii Study ◽  
Small Cell ◽  
Second Line ◽  
Small Cell Lung ◽  
Second Line Chemotherapy ◽  
Line Chemotherapy

Phase II study of oxaliplatin as second-line chemotherapy in endometrial carcinoma: A Gynecologic Oncology Group study

2006 ◽  
Vol 103 (2) ◽  
pp. 523-526 ◽  
Author(s):  
Paula M. Fracasso ◽  
John A. Blessing ◽  
Kelly L. Molpus ◽  
Lisa M. Adler ◽  
Joel I. Sorosky ◽  
...  
Keyword(s):  
Endometrial Carcinoma ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Gynecologic Oncology ◽  
Gynecologic Oncology Group ◽  
Second Line ◽  
Oncology Group ◽  
Oncology Group Study ◽  
Second Line Chemotherapy ◽  
Line Chemotherapy

A randomized phase II study of raltitrexed and gefitinib versus raltitrexed alone as second line chemotherapy in patients with colorectal cancer. (1839IL/0143)

2010 ◽  
Vol 29 (5) ◽  
pp. 1038-1044 ◽  
Author(s):  
José María Viéitez ◽  
Manuel Valladares ◽  
Ignacio Peláez ◽  
Luis de Sande González ◽  
Jesús García-Foncillas ◽  
...  
Keyword(s):  
Colorectal Cancer ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Second Line ◽  
Second Line Chemotherapy ◽  
Randomized Phase Ii ◽  
Line Chemotherapy

scholarly journals Phase II study of palliative S-1 in combination with cisplatin as second-line chemotherapy for gemcitabine-refractory pancreatic cancer patients

2012 ◽  
Vol 3 (6) ◽  
pp. 1314-1318 ◽  
Author(s):  
HYUN JUNG KIM ◽  
JINA YUN ◽  
HAN JO KIM ◽  
KYOUNG HA KIM ◽  
SE HYUNG KIM ◽  
...  
Keyword(s):  
Pancreatic Cancer ◽  
Cancer Patients ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Second Line ◽  
Second Line Chemotherapy ◽  
Gemcitabine Refractory ◽  
Line Chemotherapy
Sign in / Sign up

Export Citation Format

Share Document